Use of ranolazine for the treatment of cardiovascular diseases

Details for Australian Patent Application No. 2009214639 (hide)

Owner CV Therapeeutics, Inc.

Inventors Wolff, Andrew; Lange, Louis; Wang, Whedy; Jerling, Markus; Prokopczuk, Ewa; Belardinelli, Luiz

Agent Freehills

Pub. Number AU-A-2009214639

PCT Pub. Number WO2009/102886

Priority 12/030,468 13.02.08 US

Filing date 12 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/102886 Priority application(s): WO2009/102886

28 October 2010 Alteration of Name

  The name of the applicant has been altered to Gilead Sciences, Inc. 2009221973 201 W. Longhom, LLC The name of the applicant has been altered to Glo-Crazy Lure Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009214641-Crew transfer system

2009214636-System and method of marketing beauty products